275 related articles for article (PubMed ID: 29737910)
1. In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.
Patel NR; Piroyan A; Ganta S; Morse AB; Candiloro KM; Solon AL; Nack AH; Galati CA; Bora C; Maglaty MA; O'Brien SW; Litwin S; Davis B; Connolly DC; Coleman TP
Cancer Biol Ther; 2018 Jul; 19(7):554-564. PubMed ID: 29737910
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Characterization of Folate-Targeted Platinum-Loaded Theranostic Nanoemulsions for Therapy and Imaging of Ovarian Cancer.
Patel NR; Piroyan A; Nack AH; Galati CA; McHugh M; Orosz S; Keeler AW; O'Neal S; Zamboni WC; Davis B; Coleman TP
Mol Pharm; 2016 Jun; 13(6):1996-2009. PubMed ID: 27170232
[TBL] [Abstract][Full Text] [Related]
3. Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer.
Ganta S; Singh A; Rawal Y; Cacaccio J; Patel NR; Kulkarni P; Ferris CF; Amiji MM; Coleman TP
Drug Deliv; 2016; 23(3):968-80. PubMed ID: 24901206
[TBL] [Abstract][Full Text] [Related]
4.
Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M
Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
6. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
7. EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer Therapy.
Ganta S; Singh A; Kulkarni P; Keeler AW; Piroyan A; Sawant RR; Patel NR; Davis B; Ferris C; O'Neal S; Zamboni W; Amiji MM; Coleman TP
Pharm Res; 2015 Aug; 32(8):2753-63. PubMed ID: 25732960
[TBL] [Abstract][Full Text] [Related]
8. Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy.
Yadav S; Gupta S
Artif Cells Nanomed Biotechnol; 2015 Apr; 43(2):93-102. PubMed ID: 24195582
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
10. Theranostic Nanoparticles Loaded with Imaging Probes and Rubrocurcumin for Combined Cancer Therapy by Folate Receptor Targeting.
Alberti D; Protti N; Franck M; Stefania R; Bortolussi S; Altieri S; Deagostino A; Aime S; Geninatti Crich S
ChemMedChem; 2017 Apr; 12(7):502-509. PubMed ID: 28217982
[TBL] [Abstract][Full Text] [Related]
11. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
[TBL] [Abstract][Full Text] [Related]
12. Folate Modified Long Circulating Nano-Emulsion as a Promising Approach for Improving the Efficiency of Chemotherapy Drugs in Cancer Treatment.
Song B; Wu S; Li W; Chen D; Hu H
Pharm Res; 2020 Nov; 37(12):242. PubMed ID: 33188481
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
Jiang S; Gong X; Zhao X; Zu Y
Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
[TBL] [Abstract][Full Text] [Related]
14.
Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
[No Abstract] [Full Text] [Related]
15. Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
Wang L; Li M; Zhang N
Int J Nanomedicine; 2012; 7():3281-94. PubMed ID: 22802688
[TBL] [Abstract][Full Text] [Related]
16. AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging.
Chauhan M; Sonali ; Shekhar S; Yadav B; Garg V; Dutt R; Mehata AK; Goswami P; Koch B; Muthu MS; Singh RP
Biomater Adv; 2024 Jun; 160():213833. PubMed ID: 38564997
[TBL] [Abstract][Full Text] [Related]
17. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M
J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681
[TBL] [Abstract][Full Text] [Related]
18. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
[TBL] [Abstract][Full Text] [Related]
19. Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer.
Ganta S; Singh A; Patel NR; Cacaccio J; Rawal YH; Davis BJ; Amiji MM; Coleman TP
Pharm Res; 2014 Sep; 31(9):2490-502. PubMed ID: 24643932
[TBL] [Abstract][Full Text] [Related]
20. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]